Cytotheryx, Inc. announced today it has acquired the intellectual property assets of Ambys Medicines, Inc., which will now become part of our portfolio.
Partner with Cytotheryx
Our partners help equip us with the tools, information, and support needed to achieve our mission. As we continue to develop a consistent, high-quality source of primary human hepatocytes, or liver cells, and apply those cells to multiple research and clinical applications, our partners are an important part of our success. With the guidance of global leaders in research, development, and healthcare, including Mayo Clinic, Precigen Exemplar, and Children’s Minnesota, we have made strides toward a world with improved access to high-quality primary human hepatocytes.